← Back to Search

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

N/A
Recruiting
Research Sponsored by Jewish General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Presence of patent foramen ovale
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial will measure the improvement in lung function in patients with CTEPH before and after a balloon pulmonary angioplasty to open narrowed pulmonary arteries.

Who is the study for?
This trial is for patients with chronic thromboembolic pulmonary hypertension who are candidates for a procedure called balloon pulmonary angioplasty. People taking certain blood pressure medications or those with a heart condition known as patent foramen ovale cannot participate.
What is being tested?
The study aims to measure the recovery of functional capillary surface area in the lungs of patients undergoing balloon pulmonary angioplasty, which is a treatment to widen narrowed arteries caused by chronic blood clots.
What are the potential side effects?
Since this trial focuses on measuring lung function rather than testing a new drug or medical intervention, there are no direct side effects from the measurement process itself.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am taking medication for high blood pressure.
Select...
I have a hole in my heart that didn't close after birth.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Increase in pulmonary functional capillary surface area

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pre and post BPAExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Jewish General HospitalLead Sponsor
140 Previous Clinical Trials
278,528 Total Patients Enrolled

Media Library

Balloon Pulmonary Angioplasty Clinical Trial Eligibility Overview. Trial Name: NCT05719415 — N/A
Pulmonary Hypertension Research Study Groups: Pre and post BPA
Pulmonary Hypertension Clinical Trial 2023: Balloon Pulmonary Angioplasty Highlights & Side Effects. Trial Name: NCT05719415 — N/A
Balloon Pulmonary Angioplasty 2023 Treatment Timeline for Medical Study. Trial Name: NCT05719415 — N/A
~3 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top